Background: Infants with exomphalos major have a high mortality and morbidity. The aims of this study were to identify predictors of survival regardless of the size of the exomphalos, and to analyze morbidity in infants with exomphalos minor. Methods: Patients were classified as having exomphalos major or minor based on whether the liver was in the exomphalos sac, and the size of the abdominal wall defect. The respiratory, gastrointestinal and surgical outcomes of 50 infants with exomphalos (including 27 with exomphalos major) were assessed. Receiver operating characteristic (ROC) curves were constructed to identify factors predictive of survival.
Exomphalos is a relatively common congenital abnormality: in one study an incidence of approximately 1 in 4,000-7,000 live births was reported. 1 A study from the USA estimated a prevalence of 1.86 (95%CI: 1.73-1.99) per 10 000 live births. 2 And according to data from six regional congenital anomaly registers in England and Wales between 2005 and 2011, the overall birth prevalence of exomphalos was 3.8 per 10 000 births; 1.4 per 10 000 isolated cases; 1.2 per 10 000 cases with multiple anomalies; and 1.2 per 10 000 cases with chromosomal anomalies. 3 The 1 year survival of live-born babies with an isolated exomphalos was 92% compared with 81% in cases of multiple anomalies, and 27% in cases of chromosomal abnormalities (P < 0.001). 3 A previous study from King's College Hospital (KCH) NHS Foundation Trust, however, noted that <10% of the 445 antenatally diagnosed cases reached operative repair. 4 Fetal exomphalos diameter/abdominal circumference ratio (OD/AC) ≥0.26 has been reported to be associated with increased respiratory, gastrointestinal and surgical morbidities. 5 In another study, survival and length of stay differed between live-born non-isolated and isolated exomphalos diagnosed on prenatal ultrasound. 6 The outcomes of infants with exomphalos minor, however, have rarely been reported. The aims of this study were therefore to identify predictors of survival regardless of the size of the exomphalos and to determine whether infants with exomphalos minor also had morbidity.
Methods
A review was conducted of the outcomes of all infants with an antenatal diagnosis of exomphalos live born between 2004 and 2015 at King's College Hospital (KCH) NHS Foundation Trust. The infants were identified from a neonatal database, the neonatal unit admission book and a surgical database. Exomphalos major was defined as a defect with >50% of the liver in the exomphalos sac and an abdominal wall defect >5 cm in diameter. Infants with smaller defects were diagnosed as having exomphalos minor. None of the infants had cardiac defects, suggesting that fetuses were more likely to be terminated if they had exomphalos and other anomalies including cardiac defects. In addition, fetuses with major cardiac anomalies without other anomalies were preferentially delivered at the regional cardiac center.
Data retrieved from the medical records included birthweight, gestational age at birth, gender and antenatal genetic test results. The duration of mechanical ventilation, mode of ventilation including high-frequency oscillatory ventilation (HFOV), duration of supplemental oxygen, need for inhaled nitric oxide (iNO) or postnatal corticosteroids and mortality were also recorded. Bronchopulmonary dysplasia was defined as supplementary oxygen dependence at ≥28 days after birth. Postnatal corticosteroids were considered for infants who remained ventilator dependent with high peak inspiratory pressure and inspired oxygen concentration at ≥2 weeks of age. Details of gastrointestinal outcomes including the time to commence and reach full enteral feeds were documented, as were the length of hospital stay and time to first operative intervention. Infants underwent primary closure, staged closure or delayed closure according to the size of the defect and the infant's respiratory status, that is, a more conservative approach was undertaken for infants requiring a high level of respiratory support.
Statistical analysis
The data were tested for normality using the KolmogorovSmirnov test and found not to be normally distributed. Differences, therefore, were assessed for statistical significance using the Mann-Whitney U-test or chi-squared test as appropriate. Receiver operating characteristic (ROC) curves were constructed and the area under the ROC curve (AUROC) calculated to compare the predictive value of factors that differed on univariate analysis at P ≤ 0.1. Sensitivities and specificities were calculated for factors found to be most predictive. Analysis was performed using SPSS version 22.0 (SPSS, Chicago, IL, USA).
Results
Fifty infants with exomphalos were live born during the study period, 27 of whom had exomphalos major. There were no significant differences in birthweight (P = 0.073) or gestational age (P = 0.129) between those with major or minor abnormalities ( Table 1) . None of the infants in either group had cardiac anomalies. Six infants in the exomphalos minor group had the genetic diagnosis of Beckwith-Wiedemann syndrome and one infant in the exomphalos major group had a minor genetic abnormality with duplication in the short arm of chromosome 8. The time to first surgical intervention occurred later in infants with exomphalos major (4 vs 2 days, P = 0.002). Infants with exomphalos major had significantly worse adverse respiratory outcomes with longer median duration of mechanical ventilation (P < 0.001) and supplemental oxygen (P < 0.001) and a greater need for HFOV (P = 0.008; Table 1 ). Infants with exomphalos major compared with minor commenced enteral feeds (P = 0.004) and achieved full enteral feeds (P < 0.001) at a greater postnatal age (Table 1) . In both groups, however, a proportion of infants required nasogastric feeding at discharge: 37% in the exomphalos major and 17% in the exomphalos minor groups. The length of hospital stay was longer in infants with exomphalos major (P < 0.001; Table 1 ). Infants with exomphalos minor who had chromosomal abnormalities developed severe respiratory distress or chronic respiratory morbidity. No infant with exomphalos minor who did not have chromosomal abnormalities developed severe respiratory distress (as defined by the need for HFOV or iNO) or chronic respiratory morbidity (defined as development of BPD or need for postnatal corticosteroids; Table 1 ).
There were seven deaths in the exomphalos major group and none in the exomphalos minor group (P < 0.001). Infants who did not survive were born at an earlier gestational age © 2018 Japan Pediatric Society (P = 0.006) and at smaller birthweight (P = 0.01) and needed longer duration of mechanical ventilation (P < 0.001) and supplementary oxygen (P < 0.001; Table 2 ). A greater proportion of the non-survivors required iNO (P = 0.001), HFOV (P < 0.001) and postnatal steroids (P = 0.048; Table 2 ). In the overall study group, gestational age >35 weeks had an AUROC of 0.814 and a sensitivity of 83% and 72%; and birthweight >2,497 g had an AUROC of 0.797 and a sensitivity of 82% and a specificity of 72% in prediction of survival. Mechanical ventilation >15 days had an AUROC of 0.853 with a sensitivity of 85% and a specificity of 80%; and duration of supplemental oxygen >40 days had an AUROC of 0.810 with a sensitivity of 72% and a specificity of 85% in prediction of mortality.
Discussion
We have shown that infants with exomphalos born at lower gestational age and birthweight are at increased risk of mortality. The overall mortality of live-born infants with exomphalos in the present series was 14%, similar to that reported previously. 7 Importantly, we have also shown that infants with exomphalos minor can have chronic morbidity, as evidenced by the requirement for nasogastric tube feeding at discharge.
Prolonged requirement for mechanical ventilation and for supplementary oxygen were also sensitive and specific predictors of survival. This suggests that infants with exomphalos are at increased risk of pulmonary hypoplasia due to reduced fetal breathing because of poor diaphragmatic function in utero. Indeed, infants with anterior wall defects (AWD) have been shown to have impaired postnatal lung function. 8 Infants with AWD studied at a median age of 5 months had significantly lower functional residual capacity (FRC) than healthy age-matched controls. 8 Furthermore, children who had had giant exomphalos, when studied at median age of 19.7 months (range, 1-58 months), had reduced lung volume, increased airway hyperresponsiveness and reduced respiratory system-specific compliance. 9 Herein we have reported a higher incidence of genetic abnormalities in infants with exomphalos minor compared with exomphalos major. This is likely explained by the inclusion of only live-born infants, given that fetuses of pregnancies that were terminated or resulted in intrauterine deaths would be likely to have had multiple congenital abnormalities and/or severe chromosomal abnormalities. Indeed, a previous study from the present institution reported that <10% of all cases of antenatally diagnosed exomphalos reach an operative stage. 4 In 56% of the cases (n = 250) there was an abnormal karyotype and from that group there were only two live births. 4 In an observational study of 53 patients with gastroschisis and 43 with exomphalos there were no significant differences in outcomes between those who were and were not diagnosed antenatally. 10 The rate of antenatal detection, however, was low (overall, 44%) and there was a low rate of chromosomal abnormalities. It has been suggested that despite advances in ultrasound technology, its ability to predict an abnormal karyotype in exomphalos fetuses has not improved. 11 In the present series of live-born infants, only one infant with exomphalos major had a chromosomal abnormality and this was of a minor nature, which likely reflects the antenatal detection of major chromosomal anomalies and the opting for termination of pregnancy or stillbirth.
Infants with exomphalos major had significantly worse respiratory outcomes compared with those with exomphalos minor, as evidenced by the longer duration of mechanical ventilation and supplemental oxygen and the requirement for HFOV and/or iNO. Exomphalos minor infants with chromosomal abnormalities, however, had severe respiratory distress or chronic respiratory morbidity. Infants with giant exomphalos complicated by pulmonary hypertension have been reported to have increased respiratory support requirements with a longer duration of mechanical ventilation, requirement for tracheotomy and dependence on home oxygen therapy following hospital discharge compared with survivors with no associated pulmonary hypertension. 12 In a series of 54 infants with giant exomphalos, 37% had pulmonary hypertension. 12 A proportion of infants in the present series, more with exomphalos major, required iNO and thus likely had pulmonary hypertension.
We have also shown that infants with exomphalos have chronic gastrointestinal problems. The time taken to start and achieve full enteral feeds differed significantly between the two groups, but there were no significant differences in birthweight or gestational age between the two groups and none had a cardiac defect. The differences in the time to start and achieve full enteral feeds likely reflects the more severe respiratory abnormalities in the exomphalos major group. Importantly, 37% of the major group and 17% of the minor group required nasogastric feeding after discharge, therefore parents need to be informed that this is a possible outcome. In this study infants had primary closure or had a silo fashioned. In a recent study of infants with giant exomphalos treated by negative pressure wound therapy, full feeds were achieved by a postnatal age of 19 days and full closure of the abdominal wall defect by 2 months of age. 13 Whether such an approach would produce better outcomes than current strategies requires testing in a randomized trial.
In conclusion, infants with exomphalos born at an earlier gestation and at lower birthweight are more likely to die. In addition, a requirement for prolonged ventilation and supplementary oxygen also predicted mortality, likely reflecting the presence of pulmonary hypoplasia. Infants with exomphalos minor did have morbidity, and these data should be helpful to inform counseling of parents of affected infants.
